Press Releases

Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases. Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based...

Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.  ...

Covance Inc. , one of the world's largest and most comprehensive drug development companies, and PathoQuest, a pioneer in the field of pathogen detection, today announce an exclusive agreement to collaborate in providing Next-Generation Sequencing (NGS) based biosafety assessments. ...

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has completed its efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy...

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology. MedImmune has also entered into...

3rd Biotechnology World Congress hosted by Eureka Science Ltd. is a highly reputed event withing the industry. In the year 2014 is is getting conducted from 10th February to 12th February has now announced the list of their Advisory...

6th International Conference on Drug Discovery and Therapy, a highly reputed event withing the sector which is hosted by Eureka Science Ltd. is getting conducted from 10th February to 12th February in the year 2014 announced the list of...